Constellation Brands
Beer and wine company that owns the exclusive US rights to sell Corona and Modelo.
The company's real risk is tariffs and softening Hispanic-consumer demand, not AI or a rival brewer, since the law itself keeps AB InBev off its lawn.
Constellation Brands owns the exclusive U.S. rights to Corona and Modelo beers, two of America's top-selling brands. A 2013 court settlement legally prevents Anheuser-Busch (the larger global beer company) from selling these brands in the United States, which gives Constellation a unique advantage that no competitor can easily copy or replace. The real threat to the company is not a rival or new technology, but U.S. tariff policy on Mexican beer imports and aluminum cans: if tariffs rise significantly, Constellation's profits would shrink because the company cannot simply move production to avoid the taxes, and this risk remains the biggest unknown factor ahead.
Whether U.S. tariffs on Mexican beer/aluminum imports rise above current levels. Tests if Constellation can keep passing costs through without margin damage.
Whether CEO Nicholas Fink's 'occasion-based' strategy produces visible sales or margin shifts by FY27 year-end. Shows whether new leadership's plan is working or stalling.
- $9.14B revenue, 30% operating margin
- 23.4% US beer share vs Molson Coors 14.2%
- Stock down 45% from 2024 highs, $22.7B market cap
- Escalating U.S. tariffs on Mexican beer imports and aluminum could compress margins with no domestic-production escape hatch.
- Persistent demand softness among Hispanic consumer cohort tied to macro and immigration anxiety, 2026.
- New CEO Nicholas Fink (effective April 2026) still in early execution of untested growth strategy.
- Minority stake in financially distressed Canopy Growth (stock under $1) adds equity volatility.
- Mixed analyst sentiment with multiple July 2026 price-target cuts signals market skepticism on near-term execution.
| Rival | Direction | Evidence |
|---|---|---|
| Anheuser-Busch InBev | losing to | Legally barred from selling Corona/Modelo in the U.S. under 2013 antitrust settlement |
| Molson Coors | gaining on | Constellation holds ~23.4% U.S. beer share vs Molson Coors' ~14.2% in 2026 |
| Brown-Forman | contesting | Competes directly in tequila category via Herradura vs Constellation's Casa Noble |
| E. & J. Gallo / The Wine Group | contesting | Absorbed Constellation's divested mainstream wine brands in June 2025 deal |
| Diageo | contesting | Competes in premium spirits as Constellation narrows to $15+ wine/spirits portfolio, 2026 |
- Is Constellation Brands profitable in 2026?
- Yes. Constellation Brands reported FY2026 (ended Feb 28, 2026) net sales of $9.14 billion and operating income of $2.72 billion, roughly a 30% margin, with $1.8 billion in free cash flow, per company earnings recap.
- Could AI replace Constellation Brands?
- No. Constellation's moat is a perpetual, exclusive U.S. license for Corona and Modelo won in a 2013 antitrust settlement, plus distributor lock-in and Mexican brewery capital. AI only touches internal demand forecasting and logistics, not the core licensed product or distribution network.
- Who is Constellation Brands' biggest competitor?
- Molson Coors is the closest domestic beer rival, holding about 14.2% U.S. beer market share versus Constellation's roughly 23.4% in 2026. Anheuser-Busch InBev is the larger global incumbent but is legally barred from selling Corona/Modelo in the U.S. under a 2013 antitrust settlement.
- Who owns Constellation Brands?
- Constellation Brands is publicly traded on the NYSE (STZ) with a dual-class share structure. Company insiders, including the founding Sands family, own about 12.2% of stock, while institutional and hedge-fund holders own roughly 77%, as of July 20, 2026.
- Why is Constellation Brands' stock down in 2026?
- Constellation's stock has fallen about 45% from 2024 highs, trading near $130-140 with a market cap of roughly $22.7 billion as of July 20, 2026, driven by tariff uncertainty, softening Hispanic-consumer demand, and a CEO transition.
- Does Constellation Brands still rely on wine and spirits?
- No, beer now drives about 91% of total net sales (roughly $8.3 billion of $9.1 billion in FY26), after Constellation sold mainstream wine brands like Woodbridge and Meiomi to The Wine Group in June 2025, shrinking Wine & Spirits to about $824 million.
- 2026-07-01FY27 guidance issued: comparable EPS $11.20-11.90, FCF $1.6-1.7B
- 2026-05-31Q1 FY27 net sales $2.433B, down 3% YoY, beer segment +2%
- 2026-04-13Nicholas I. Fink becomes President and CEO, succeeding William Newlands
- 2026-02-28FY2026 ends: net sales $9.14B, operating income $2.72B, FCF $1.8B
- 2026-02-128-K filed announcing Fink as incoming CEO
- 2025-07-03Company discloses estimated $70M beer, $20M wine tariff impact for FY26
- 2025-06-02Closes sale of mainstream wine brands to The Wine Group
- 2025-04-09Announces $2B capex plan (FY26-28) including new Veracruz brewery
- 2013Constellation obtains exclusive perpetual U.S. Corona/Modelo license via AB InBev antitrust settlement
- Constellation Brands earnings recap FY26
- Zacks/Yahoo Finance (2026-07-01)
- The Modelo Moat at a Discount (2026-05-06)
- BeverageDaily (2025-07-03)
- Constellation Brands 8-K (2026-02-12)
- Pitchbook
- stockanalysis.com
- Brewbound (2025-04-09)
- Motley Fool earnings transcript (2025-10-07)